"point in time" regulation content Health professions act Pharmacists regulation B.c. reg. 417/2008 Note:
Links below go to regulation content as it was prior to the Changes made on the effective date. (pit covers changes made From september 19, 2009 to "current to" date of the Regulation.)
Section
Effective date Section 1
October 9, 2009
July 26, 2016
June 1, 2023
Section 2
January 1, 2011
Section 4
October 9, 2009
October 30, 2009
December 3, 2015
June 1, 2023
Section 4.1
October 9, 2009
July 26, 2016
June 1, 2023
Schedule a June 1, 2023
Section 1 definition of "practice of pharmacy", paragraph (a.1) was Added by bc reg 234/2009, effective october 9, 2009.
Section 1 definition of "substance" was added by bc reg 234/2009, Effective october 9, 2009.
Section 1 definition of "medical assistance in dying" was added by Bc reg 201/2016, effective july 26, 2016.
Section 1 definition of "practice of pharmacy", paragraph (a.1) Before amended by bc reg 111/2023, effective june 1, 2023.
(a.1) Promoting health and preventing diseases, disorders and conditions Through drug therapy, Section 1 definition of "substance" before amended by bc reg 111/2023, effective june 1, 2023.
"substance" Means a drug that is not specified in schedule i, ia, ii or iv of The drug schedules regulation.
Section 2 (e) was added by bc reg 211/2010, effective january 1, 2011.
Section 4 (1) (c.1) was added by bc reg 234/2009, effective october 9, 2009.
Section 4 (1) (c.1) before amended by bc reg 256/2009, effective October 30, 2009.
(c.1) in respect of a drug specified in schedule i, ia or ii of The drug schedules regulation or a substance, (i)  administer the drug or substance by intramuscular or Subcutaneous injection, or (ii)  administer the drug or substance by any method for the Purpose of treating anaphylaxis arising from administering a drug or Substance by intradermal, intramuscular or subcutaneous injection, As described in subparagraph (i); Section 4 (1) (c.1) (i) and (ii) before amended by bc reg 225/2015, Effective december 3, 2015.
(i) Administer the drug or substance by intradermal, intramuscular or Subcutaneous injection, or (ii) Administer the drug or substance by any method for the purpose of Treating anaphylaxis arising from administering a drug or substance By intradermal, intramuscular or subcutaneous injection, as Described in subparagraph (i); Section 4 (1) (a), (b) and (c) before amended by bc reg 111/2023, Effective june 1, 2023.
(a) Prescribe a drug specified in schedule iv of the drug schedules Regulation to be used for emergency contraception; (b) Compound a drug specified in schedule i, ia, ii or iv of The drug schedules regulation; (c) Dispense a drug specified in schedule i, ia, ii or iv of The drug schedules regulation; Section 4 (a.1) and (a.2) were added by bc reg 111/2023, effective June 1, 2023.
Section 4.1 was enacted by bc reg 234/2009, effective october 9, 2009.
Section 4.1 was renumbered as section 4.1 (1) and (2) was added by Bc reg 201/2016, effective july 26, 2016.
Section 4.1 (1) was renumbered as section 4.1 (1.1) and (1) was Added by bc reg 111/2023, effective june 1, 2023.
Schedule a was enacted by bc reg 111/2023, effective june 1, 2023.